Solesence, Inc. (SLSN) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Win; EPS growth Lose.
45/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 2 wins, 10 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseSLSN / S&P -22.11% / 15.20% |
LoseSLSN / S&P -14.05% / 15.00% |
LoseSLSN / S&P -142.86% / 50.40% |
| 2026-Q10/3 |
LoseSLSN / S&P -40.63% / -4.33% |
LoseSLSN / S&P 5.76% / 11.30% |
LoseSLSN / S&P -75.00% / 27.70% |
| 2025-Q41/3 |
LoseSLSN / S&P -50.31% / 2.65% |
WinSLSN / S&P 18.56% / 9.00% |
LoseSLSN / S&P -66.67% / 13.40% |
| 2025-Q31/3 |
LoseSLSN / S&P -26.15% / 8.12% |
WinSLSN / S&P 30.04% / 4.61% |
LoseSLSN / S&P -66.67% / 13.45% |
| 2025-Q22/3 |
WinSLSN / S&P 112.68% / 10.94% |
WinSLSN / S&P 65.67% / 4.83% |
LoseSLSN / S&P -275.00% / 10.63% |
| 2025-Q11/3 |
LoseSLSN / S&P -15.98% / -4.27% |
WinSLSN / S&P 51.43% / 4.98% |
LoseSLSN / S&P -200.00% / 10.57% |
| 2024-Q42/3 |
WinSLSN / S&P 50.62% / 2.41% |
WinSLSN / S&P 40.35% / 5.25% |
LoseSLSN / S&P -175.00% / 6.15% |
| 2024-Q31/3 |
LoseSLSN / S&P 4.52% / 5.89% |
WinSLSN / S&P 27.28% / 5.89% |
LoseSLSN / S&P -137.50% / 6.11% |
| 2024-Q21/3 |
WinSLSN / S&P 121.43% / 4.28% |
LoseSLSN / S&P -0.98% / 5.38% |
LoseSLSN / S&P -42.86% / 5.12% |
| 2024-Q11/3 |
WinSLSN / S&P 16.67% / 10.56% |
LoseSLSN / S&P -2.35% / 5.71% |
LoseSLSN / S&P -50.00% / 5.59% |
| 2023-Q41/3 |
LoseSLSN / S&P -31.82% / 11.69% |
LoseSLSN / S&P -0.05% / 6.81% |
WinSLSN / S&P 33.33% / 7.78% |
| 2023-Q31/3 |
LoseSLSN / S&P -36.69% / -3.27% |
LoseSLSN / S&P 3.09% / 7.52% |
WinSLSN / S&P 166.67% / -5.03% |
| 2023-Q21/3 |
LoseSLSN / S&P 8.59% / 8.74% |
WinSLSN / S&P 13.27% / 9.50% |
LoseSLSN / S&P -450.00% / -8.57% |
| 2023-Q12/3 |
WinSLSN / S&P 13.27% / 7.50% |
WinSLSN / S&P 26.37% / 10.77% |
LoseSLSN / S&P -500.00% / -15.69% |
| 2022-Q41/3 |
LoseSLSN / S&P -52.32% / 7.56% |
WinSLSN / S&P 26.61% / 11.88% |
LoseSLSN / S&P -220.00% / -17.99% |
| 2022-Q31/3 |
LoseSLSN / S&P -19.93% / -4.88% |
WinSLSN / S&P 35.04% / 13.47% |
LoseSLSN / S&P -142.86% / -1.41% |
| 2022-Q21/3 |
LoseSLSN / S&P -20.00% / -16.10% |
WinSLSN / S&P 51.15% / 13.71% |
LoseSLSN / S&P -60.00% / 11.04% |
| 2022-Q11/3 |
LoseSLSN / S&P -15.91% / -4.60% |
WinSLSN / S&P 51.61% / 15.97% |
LoseSLSN / S&P -66.67% / 42.23% |
| 2021-Q42/3 |
WinSLSN / S&P 60.58% / 11.03% |
WinSLSN / S&P 72.14% / 15.00% |
LoseSLSN / S&P 66.67% / 96.40% |
| 2021-Q32/3 |
WinSLSN / S&P 63.10% / 0.58% |
WinSLSN / S&P 84.06% / 10.77% |
LoseSLSN / S&P -2017612633061981952.00% / 69.42% |
| 2021-Q22/3 |
WinSLSN / S&P 38.84% / 8.55% |
WinSLSN / S&P 65.79% / 6.58% |
LoseSLSN / S&P -266.67% / 51.81% |
| 2021-Q12/3 |
WinSLSN / S&P 42.35% / 6.17% |
WinSLSN / S&P 57.55% / -1.06% |
LoseSLSN / S&P -200.00% / 7.39% |
| 2020-Q42/3 |
WinSLSN / S&P 37.10% / 12.15% |
WinSLSN / S&P 36.89% / -3.72% |
LoseSLSN / S&P SLSN unavailable / -33.42% |
| 2020-Q32/3 |
WinSLSN / S&P 29.17% / 8.93% |
WinSLSN / S&P 10.38% / -2.04% |
LoseSLSN / S&P SLSN unavailable / -27.10% |
| 2020-Q21/3 |
WinSLSN / S&P 128.57% / 20.54% |
LoseSLSN / S&P -2.77% / -0.46% |
LoseSLSN / S&P SLSN unavailable / -27.11% |
| 2020-Q10/3 |
LoseSLSN / S&P -25.00% / -19.60% |
LoseSLSN / S&P -15.00% / 3.47% |
LoseSLSN / S&P SLSN unavailable / -14.75% |
| 2019-Q40/3 |
LoseSLSN / S&P -39.13% / 9.07% |
LoseSLSN / S&P -11.87% / 5.36% |
LoseSLSN / S&P SLSN unavailable / 2.99% |
| 2019-Q30/3 |
LoseSLSN / S&P -11.54% / 1.70% |
LoseSLSN / S&P -2.78% / 5.02% |
LoseSLSN / S&P SLSN unavailable / 0.21% |
| 2019-Q21/3 |
LoseSLSN / S&P 4.00% / 4.30% |
WinSLSN / S&P 14.58% / 6.64% |
LoseSLSN / S&P SLSN unavailable / 8.65% |
| 2019-Q11/3 |
LoseSLSN / S&P -31.51% / 13.65% |
WinSLSN / S&P 26.64% / 8.12% |
LoseSLSN / S&P SLSN unavailable / 14.29% |
| 2018-Q42/3 |
WinSLSN / S&P -2.67% / -13.52% |
WinSLSN / S&P 13.81% / 9.05% |
LoseSLSN / S&P SLSN unavailable / 18.23% |
| 2018-Q31/3 |
LoseSLSN / S&P -21.88% / 7.71% |
WinSLSN / S&P 11.74% / 10.21% |
LoseSLSN / S&P SLSN unavailable / 19.06% |
| 2018-Q21/3 |
WinSLSN / S&P 108.70% / 3.43% |
LoseSLSN / S&P 3.86% / 9.03% |
LoseSLSN / S&P SLSN unavailable / 14.46% |
| 2018-Q10/3 |
LoseSLSN / S&P -11.54% / -0.76% |
LoseSLSN / S&P -1.43% / 7.68% |
LoseSLSN / S&P SLSN unavailable / 12.46% |
| 2017-Q41/3 |
LoseSLSN / S&P -23.53% / 6.64% |
WinSLSN / S&P 15.65% / 7.03% |
LoseSLSN / S&P SLSN unavailable / 13.82% |
| 2017-Q31/3 |
LoseSLSN / S&P 1.49% / 4.48% |
WinSLSN / S&P 14.26% / 5.68% |
LoseSLSN / S&P SLSN unavailable / 17.57% |
| 2017-Q21/3 |
LoseSLSN / S&P -4.29% / 3.09% |
WinSLSN / S&P 9.09% / 4.83% |
LoseSLSN / S&P SLSN unavailable / 17.74% |
| 2017-Q11/3 |
LoseSLSN / S&P -2.78% / 6.07% |
WinSLSN / S&P 18.04% / 3.67% |
LoseSLSN / S&P SLSN unavailable / 13.32% |
| 2016-Q41/3 |
LoseSLSN / S&P 2.86% / 3.82% |
WinSLSN / S&P 4.56% / 2.09% |
LoseSLSN / S&P SLSN unavailable / 7.05% |
| 2016-Q32/3 |
WinSLSN / S&P 6.06% / 3.85% |
WinSLSN / S&P 8.55% / 0.20% |
LoseSLSN / S&P SLSN unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | SLSN total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -74.04% | 20.78% |
| Annualized return | -74.04% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | SLSN total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -61.22% | 83.14% |
| Annualized return | -17.26% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | SLSN total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 26.67% | 319.30% |
| Annualized return | 2.39% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axil Brands, Inc. (AXIL) | United States | $0.042B | 17.24 |
| UNITED GUARDIAN INC (UG) | United States | $0.034B | 13.30 |
| Caring Brands, Inc. (CABR) | United States | $0.013B | |
| BONK, INC. (BNKK) | United States | $0.011B | -0.14 |
| cbdMD, Inc. (YCBD) | United States | $0.005B | -2.59 |
| EDGEWELL PERSONAL CARE Co (EPC) | United States | $1.261B | -13.27 |
| COTY INC. (COTY) | United States | $2.307B | -3.15 |
| INTERPARFUMS INC (IPAR) | United States | $3.707B | 21.36 |
| e.l.f. Beauty, Inc. (ELF) | United States | $5.934B | |
| Kenvue Inc. (KVUE) | United States | $33.844B | 22.14 |